Drug profile · INN
fostamatinib disodium
TAVALISSE
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
fostamatinib disodium (TAVALISSE) is an FDA-listed pharmaceutical active ingredient. Associated with RIGEL PHARMACEUTICALS INC. Route of administration: oral. Current US regulatory status: approved.
Key facts
INN fostamatinib disodium
Brand TAVALISSE
Route ORAL
Formulation TABLET
Originator RIGEL PHARMACEUTICALS INC
Frequently asked questions
What is fostamatinib disodium?
fostamatinib disodium (TAVALISSE) is an FDA-listed pharmaceutical active ingredient. Associated with RIGEL PHARMACEUTICALS INC. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for fostamatinib disodium?
TAVALISSE is a marketed brand name for fostamatinib disodium. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of fostamatinib disodium?
fostamatinib disodium has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.